Professor Ranjeny Thomas of the UQ Diamantina Institute has been named a finalist in the GlaxoSmithKline Awards for Research Excellence.

Two researchers from The University of Queensland have been named finalists in one of Australia’s longest running and most prestigious medical research awards: the GlaxoSmithKline Awards for Research Excellence.

31 July 2012
Dr Michelle Hill has been awarded an ARC Future Fellowship.

The University of Queensland Diamantina Institute's Dr Michelle Hill has been announced a winner of a Australian Research Council (ARC) Future Fellowship to study the total cellular effect of cancer-associated changes in cellular membranes.

31 July 2012
Professor Ian Frazer with the Gardasil vaccine.

In a world first, Australian schoolboys will be able to receive the Gardasil vaccine, protecting them against developing a range of cancers - a move which will improve the effectiveness of the vaccine in women.

13 July 2012
AIBN Director Professor Peter Gray.

An international collaboration involving the development of next-generation of smart medicines in Brisbane has received a boost, with $485,000 in State Government funding

19 June 2012

The University of Queensland Diamantina Institute’s researchers have played a leading role in a recent study into osteoporosis, more than doubling the number of currently known genes in the disease.

27 April 2012
Professor Matt Brown (Director of the UQ Diamantina Institute) talks with Professor Ian Frazer (CEO of the TRI) and Premier Anna Bligh about UQDI’s state-of-the-art genomics facilities

The vision of a specialised centre to better understand and treat head and neck cancers will come to fruition — thanks to $15 million funding from Atlantic Philanthropies, the Queensland Government and the Princess Alexandra Hospital.

9 March 2012

Since 2005, genome-wide association studies (GWAS) have successfully identified thousands of genes responsible for common human diseases.

13 January 2012